Viewing Study NCT06049992


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2025-12-26 @ 4:07 PM
Study NCT ID: NCT06049992
Status: RECRUITING
Last Update Posted: 2023-12-29
First Post: 2023-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: STylet-driven vs. LumenlEss Lead in Left-Bundle-Branch Pacing
Sponsor: Puerta de Hierro University Hospital
Organization:

Study Overview

Official Title: Stylet-driven vs. Lumenless Lead in Left-Bundle-Branch Pacing Randomized Trial
Status: RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: STYLE-LBBP
Brief Summary: The STYLE-LBBP study aims to compare the efficacy and safety of left-bundle branch pacing between the two types of available pacing leads: lumenless vs stylet-driven.
Detailed Description: STYLE-LBBP is a randomized, non-blinded, multicenter clinical trial that compares the efficacy and safety of two types of available pacing leads in conduction system pacing (CSP). Patients referred to CSP who meet the inclusion and exclusion criteria will be enrolled and randomized into two groups: i)Left bundle branch pacing (LBBP) using leads without internal light (Lumenless; Medtronic Selectsecure 3830, Minneapolis, USA) or ii) LBBP with stylet-driven leads (Tendril STS 2088TC, Abbott, Inc., USA; Solia S60, Biotronik, SE \& Co., KG, Germany; Ingevity +, Boston Scientific, Marlborough, MA, USA).

Efficacy in terms of achieving LBBP (selective and non-selective left bundle capture criteria) will be measured at implantation and after 24 hours. Complications of the procedure will also be recorded.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: